Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lovro Kramer

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Metabolic Engineering|August 20, 2025
A genome-scale CRISPR deletion screen in Chinese hamster ovary cells reveals essential regions of the coding and non-coding genomeFederico De Marco, Ivy Rose Sebastian, Antonino Napoleone, et al.
Molecular Therapy. Methods & Clinical Development|September 13, 2021
Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cellsGuido J J Kierkels, Eline van Diest, Patricia Hernández-López, et al.
The Journal of Clinical Investigation|June 3, 2020
γ9δ2T cell diversity and the receptor interface with tumor cellsAnna Vyborova, Dennis X Beringer, Domenico Fasci, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Metabolic Engineering|August 20, 2025
A genome-scale CRISPR deletion screen in Chinese hamster ovary cells reveals essential regions of the coding and non-coding genomeFederico De Marco, Ivy Rose Sebastian, Antonino Napoleone, et al.
Molecular Therapy. Methods & Clinical Development|September 13, 2021
Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cellsGuido J J Kierkels, Eline van Diest, Patricia Hernández-López, et al.
The Journal of Clinical Investigation|June 3, 2020
γ9δ2T cell diversity and the receptor interface with tumor cellsAnna Vyborova, Dennis X Beringer, Domenico Fasci, et al.
Pageof 2